These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1967229)

  • 1. Overexpression of P-glycoprotein in rat hepatocellular carcinomas induced with N-nitrosomorpholine.
    Volm M; Zerban H; Mattern J; Efferth T
    Carcinogenesis; 1990 Jan; 11(1):169-72. PubMed ID: 1967229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of distinct multidrug-resistance (P-glycoprotein) genes during rat liver regeneration and hepatocarcinogenesis.
    Teeter LD; Estes M; Chan JY; Atassi H; Sell S; Becker FF; Kuo MT
    Mol Carcinog; 1993; 8(2):67-73. PubMed ID: 8104413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas.
    Fairchild CR; Ivy SP; Rushmore T; Lee G; Koo P; Goldsmith ME; Myers CE; Farber E; Cowan KH
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7701-5. PubMed ID: 2890168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice.
    Kuo MT; Zhao JY; Teeter LD; Ikeguchi M; Chisari FV
    Cell Growth Differ; 1992 Aug; 3(8):531-40. PubMed ID: 1356418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular pattern of multidrug-resistance gene expression during chemical hepatocarcinogenesis in the rat.
    Nakatsukasa H; Evarts RP; Burt RK; Nagy P; Thorgeirsson SS
    Mol Carcinog; 1992; 6(3):190-8. PubMed ID: 1359897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive expression of functional P-glycoprotein in rat hepatoma cells.
    Fardel O; Loyer P; Lecureur V; Glaise D; Guillouzo A
    Eur J Biochem; 1994 Jan; 219(1-2):521-8. PubMed ID: 7905826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma.
    Huang CC; Wu MC; Xu GW; Li DZ; Cheng H; Tu ZX; Jiang HQ; Gu JR
    J Natl Cancer Inst; 1992 Feb; 84(4):262-4. PubMed ID: 1346405
    [No Abstract]   [Full Text] [Related]  

  • 8. Altered transferrin gene expression in preneoplastic and neoplastic liver lesions induced in rats with N-nitrosomorpholine.
    Schiebel K; Stumpf H; Zerban H; Pekel E; Bannasch P
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(4):251-7. PubMed ID: 1359698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the multidrug resistance gene in regenerating rat liver.
    Marino PA; Gottesman MM; Pastan I
    Cell Growth Differ; 1990 Feb; 1(2):57-62. PubMed ID: 1982215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of multidrug-resistance (P-glycoprotein) genes in liver cancers: a molecular example of the convergence theory of hepatocarcinogenesis?
    Kuo MT
    Mol Carcinog; 1993; 7(2):73-5. PubMed ID: 8096140
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug resistance dependent on different molecular size P-glycoproteins in Yoshida rat ascites hepatoma cells.
    Miyamoto K; Wakusawa S; Nakamura S
    Biochem Pharmacol; 1992 Mar; 43(5):1143-5. PubMed ID: 1348175
    [No Abstract]   [Full Text] [Related]  

  • 12. Coordinate activation of multidrug-resistance (P-glycoprotein) genes mdr2 and mdr3 during mouse liver regeneration.
    Teeter LD; Chan JY; Kuo MT
    Mol Carcinog; 1991; 4(5):358-61. PubMed ID: 1680339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of P-glycoprotein and multidrug resistance in renal cell carcinoma.
    Naito S; Sakamoto N; Kotoh S; Goto K; Matsumoto T; Kumazawa J
    Eur Urol; 1993; 24(1):156-60. PubMed ID: 8103456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the multidrug resistance gene mdr3 in spontaneous and chemically induced mouse hepatocellular carcinomas.
    Teeter LD; Becker FF; Chisari FV; Li DJ; Kuo MT
    Mol Cell Biol; 1990 Nov; 10(11):5728-35. PubMed ID: 2122232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-glycoprotein expression in hepatocellular carcinoma.
    Isshiki K; Nakao A; Ito M; Hamaguchi M; Takagi H
    J Surg Oncol; 1993 Jan; 52(1):21-5. PubMed ID: 8095077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistance genes, p-glycoprotein and the liver.
    Arias IM
    Hepatology; 1990 Jul; 12(1):159-65. PubMed ID: 1973680
    [No Abstract]   [Full Text] [Related]  

  • 17. ABO blood type predicts the cytolocalization of anti-P-glycoprotein monoclonal antibody reactivity in human colon and ureter.
    Weinstein RS; Kuszak JR; Jakate SM; Lebovitz MD; Kluskens LF; Coon JS
    Hum Pathol; 1990 Sep; 21(9):949-58. PubMed ID: 1975552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection.
    Choi K; Frommel TO; Stern RK; Perez CF; Kriegler M; Tsuruo T; Roninson IB
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7386-90. PubMed ID: 1678523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of a rat hepatic oncofetal membrane glycoprotein.
    Faris RA; McEntire KD; Thompson NL; Hixson DC
    Cancer Res; 1990 Aug; 50(15):4755-63. PubMed ID: 1695125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of a multidrug resistance gene in esophageal adenocarcinoma. Correlation with response to chemotherapy and comparison with gastric adenocarcinoma.
    Robey-Cafferty SS; Rutledge ML; Bruner JM
    Am J Clin Pathol; 1990 Jan; 93(1):1-7. PubMed ID: 1967201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.